Cara Therap Company Profile
✉ Email this page to a colleague
What is the competitive landscape for CARA THERAP, and when can generic versions of CARA THERAP drugs launch?
CARA THERAP has one approved drug.
There are twelve US patents protecting CARA THERAP drugs.
There are forty-five patent family members on CARA THERAP drugs in twenty-five countries and eleven supplementary protection certificates in ten countries.
Drugs and US Patents for Cara Therap
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cara Therap | KORSUVA | difelikefalin acetate | SOLUTION;INTRAVENOUS | 214916-001 | Aug 23, 2021 | RX | Yes | Yes | 7,713,937 | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | ||
Cara Therap | KORSUVA | difelikefalin acetate | SOLUTION;INTRAVENOUS | 214916-001 | Aug 23, 2021 | RX | Yes | Yes | 8,217,007 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Cara Therap | KORSUVA | difelikefalin acetate | SOLUTION;INTRAVENOUS | 214916-001 | Aug 23, 2021 | RX | Yes | Yes | 10,793,596 | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | ||
Cara Therap | KORSUVA | difelikefalin acetate | SOLUTION;INTRAVENOUS | 214916-001 | Aug 23, 2021 | RX | Yes | Yes | 8,236,766 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Cara Therap | KORSUVA | difelikefalin acetate | SOLUTION;INTRAVENOUS | 214916-001 | Aug 23, 2021 | RX | Yes | Yes | 8,536,131 | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | ||
Cara Therap | KORSUVA | difelikefalin acetate | SOLUTION;INTRAVENOUS | 214916-001 | Aug 23, 2021 | RX | Yes | Yes | 7,727,963 | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | ||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Cara Therap Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
China | 101535336 | ⤷ Try a Trial |
Japan | 2013241447 | ⤷ Try a Trial |
Denmark | 2064228 | ⤷ Try a Trial |
Hong Kong | 1130814 | ⤷ Try a Trial |
New Zealand | 577107 | ⤷ Try a Trial |
South Korea | 20090085096 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Cara Therap Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
2064228 | CR 2022 00045 | Denmark | ⤷ Try a Trial | PRODUCT NAME: DIFELIKEFALIN; REG. NO/DATE: EU/1/22/1643 20220427 |
2064228 | 43/2022 | Austria | ⤷ Try a Trial | PRODUCT NAME: DIFELIKEFALIN ODER EIN STEREOISOMER, EINE MISCHUNG VON STEREOISOMEREN, EIN PHARMAZEUTISCH ANNEHMBARES SALZ, HYDRAT, SOLVAT, SAEURESALZHYDRAT, N-OXID, ODER EINE ISOMORPHE KRISTALLINE FORM DAVON; REGISTRATION NO/DATE: EU/1/22/1643 (MITTEILUNG) 20220427 |
2064228 | 301199 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: DIFELIKEFALIN, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT, HYDRAAT, SOLVAAT, ZUURZOUT-HYDRAAT OF N-OXIDE; REGISTRATION NO/DATE: EU/1/22/1643 20220427 |
2064228 | C02064228/01 | Switzerland | ⤷ Try a Trial | PRODUCT NAME: DIFELIKEFALIN; REGISTRATION NO/DATE: SWISSMEDIC-ZULASSUNG 68653 16.08.2022 |
2064228 | C20220035 00379 | Estonia | ⤷ Try a Trial | PRODUCT NAME: DIFELIKEFALIIN;REG NO/DATE: EU/1/22/1643 27.04.2022 |
2064228 | 22C1054 | France | ⤷ Try a Trial | PRODUCT NAME: DIFELIKEFALINE DANS TOUTES LES FORMES PROTEGEES PAR LE BREVET DE BASE; REGISTRATION NO/DATE: EU/1/22/1643 20220427 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.